Biotechnology · Healthcare
CEO, Board Member
Since 2021-01-01, last confirmed 2022-04-29
Equibles does not estimate personal net worth.
Timothy P. Noyes was last confirmed as CEO and Board Member at Jade Biosciences, Inc. (JBIO) in a filing dated April 29, 2022. Jade Biosciences, Inc. reported in an 8-K filed May 1, 2025 that Timothy P. Noyes was terminated as Aerovate's Chief Executive Officer, effective April 28, 2025. The proxy statement of Jade Biosciences, Inc. reports total compensation of $1,814,483 for Timothy P. Noyes in fiscal 2025, including a base salary of $213,767. Disclosed compensation is on record for 3 fiscal years.
“Each of Timothy P. Noyes, Aerovate's Chief Executive Officer, and George A. Eldridge, Aerovate's Chief Financial Officer, resigned as executive officers at the Closing and their employment was terminated effective April 28, 2025 (the "Separation Date"), which terminations are considered to be without "cause" related to a change in control for purposes of their employment agreements with Aerovate.”
2021-01-01–2022-04-29
Last confirmed by a filing; no departure on record
Start not stated–2022-04-29
Last confirmed by a filing; no departure on record
Biotechnology · Healthcare
CEO, Board Member
Since 2021-01-01, last confirmed 2022-04-29
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Jade Biosciences, Inc. (JBIO) | Former Chief Executive Officer | $213,767 | $1,814,483 |
| 2024 | Jade Biosciences, Inc. (JBIO) | Former Chief Executive Officer | $641,000 | $3,391,536 |
| 2021 | Jade Biosciences, Inc. (JBIO) | Chief Executive Officer | $436,833 | $5,305,461 |